BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 4, 1999
View Archived Issues
Preclinical study of TRAIL points to promise as antitumor agent
Read More
Rigel and Pfizer to collaborate in identifying drug targets in allergy and asthma
Read More
Cell Genesys reports preclinical results for Parkinson's disease gene therapy
Read More
EMEA marketing approval for Triacelluvax
Read More
Cortecs signs distribution agreement with Merck KGaA for Macritonin in Spain
Read More
Neurogen updates partnered drug development programs
Read More
N- and L-type calcium channel inhibitors developed by Ajinomoto
Read More
Production and use of KSHVIL-6/vMIP-1alpha II peptides, antibodies and antisense oligonucleotides
Read More
New GABA-A receptor ligands for anxiety, convulsions
Read More
Roche patents novel compounds interacting with group II mGluR
Read More
1,6-Naphthyridine anticonvulsants in research at SmithKline Beecham
Read More
Preparation and use of nAChR modulators disclosed by NeuroSearch
Read More
Promising early clinical results presented this week for ABT-378 in combination with ritonavir
Read More
ImmunoGen and SB enter agreement for colorectal cancer treatment
Read More
Matrix Pharmaceutical: Q4 and FY 1998 highlights
Read More
Grant to be used to study effect of P-113 in chronic lung infections
Read More
Agouron's new anti-HIV compounds profiled at AIDS conference
Read More
NIH-sponsored human clinical trials to begin with Novavax spermicide
Read More
Schering-Plough seeks approval for pediatric use of Nasonex nasal spray
Read More
First phase I clinical trials commence with NX-211
Read More
Single-dose phase I/II trial results in HIV+ adults given PRO-542 presented
Read More
Progenics identifies novel anti-HIV product
Read More
Orthovisc introduced in Israel
Read More